Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-08-27 4:04 pm Purchase | 13G | KVH INDUSTRIES INC KVHI | JEC II Associates LLC | 1,075,000 5.500% | 1,075,000 (New Position) | View |
| 2023-04-10 08:05 am Purchase | 13G | FORTE BIOSCIENCES INC FBRX | JEC II Associates LLC | 1,141,000 5.430% | 1,141,000 (New Position) | View |
| 2022-09-22 4:15 pm Sale | 13D | GYRE THERAPEUTICS INC. GYRE | JEC II Associates LLC | 0 0.000% | -2,505,000 (Position Closed) | View |
| 2022-08-01 4:15 pm Unchanged | 13D | GYRE THERAPEUTICS INC. GYRE | JEC II Associates LLC | 2,505,000 8.000% | 0 (Unchanged) | View |
| 2022-07-01 4:15 pm Unchanged | 13D | GYRE THERAPEUTICS INC. GYRE | JEC II Associates LLC | 2,505,000 8.000% | 0 (Unchanged) | View |
| 2022-06-21 5:02 pm Purchase | 13D | GYRE THERAPEUTICS INC. GYRE | JEC II Associates LLC | 2,505,000 8.000% | 2,505,000 (New Position) | View |